Abstract
RNA-seq was used to identify the partner gene and confirm the presence of a BCR-PDGFRB fusion. Identification of this fusion product resulted in successful treatment and long-term remission of this myeloid neoplasm. Based on our results, we suggest that despite current WHO recommendations, screening for PDGFRB rearrangement in cases of leukocytosis with eosinophilia and no other etiologic explanation is necessary, even if the karyotype is normal.
Cite
CITATION STYLE
Gupta, S. K., Jain, N., Tang, G., Futreal, A., Wang, S. A., Khoury, J. D., … Loghavi, S. (2020). A cryptic BCR-PDGFRB fusion resulting in a chronic myeloid neoplasm with monocytosis and eosinophilia: Anovelfindingwithtreatmentimplications. JNCCN Journal of the National Comprehensive Cancer Network, 18(10), 1300–1304. https://doi.org/10.6004/jnccn.2020.7573
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.